1. |
[1]Pearle MS, Roehrborn CG, Park CY. Meta-analysis trials for medical prevention of calcium oxalate nephrolithiasis[J]. J Endourol;13(9);679-685.
|
2. |
[2]Schepers GW. Benzbromarone therapy in hyperuricaemia; comparison with allopurinol and probenecid[J]. J Int Med Res 1981;9(6):51 1 555.
|
3. |
[3]Randomized trial of allopurinol in the prevention of calcium oxalate calculi[J]. N Engl J Med 1986;315(22): 1386-1389.
|
4. |
[4]Taylor CT, Brooks NC, Kelley KW. Corticotropin for acute management of gout. Department of Pharmacy Practice, School of Pharmacy,Auburn University, USA.
|
5. |
[5]Wurzner G, Gerster JC,Chiolero A, Maillard M, Fallab-Stubi CL,Brunner HR,Btrnier M.Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout[J].JHypertens 2001; 19(10): 1855-1860.
|
6. |
[6]Alloway JA, Moriarty MJ, Hoogland YT, Nashel DJ. Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthrisis. Rhumatology Section.Veterans Affairs Medical Center, Washington, DC 20422.
|
7. |
[7]Aher MJ, Reid C, Gordon TP, McCredie M, Brooks PM, Jones M.Does colchicines work? The results of the first controlled study in acute gout[J]. JMed 1987; 17(3):301-304.
|
8. |
[8]Alloway JA, Moriarty MJ, Hoogland YT, Nashel DJ. Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis[J]. JRheumatol 1993; 20(1); 111-113.
|
9. |
[9]Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ.Quantitative systematic review of topically applied non-steroidal anti-inflammatouy drugs[J]. BMJ 1998; 317(71530): 280-281.
|
10. |
[10]Lee A, Cooper MG, Craig JC, Knight JF, Keneally JP.The effects of nonsteroidal anti-inflammatouy drugs (NSAIDs) on postoperative renal function: a meta-analysis[J]. Anaesth Intensive Care 1999:27(6): 574-580.
|
11. |
[11]Garcia Rodriguez LA. Variability in risk of gastrointestinal complications with different nonsteroidal anti-inflammatory drugs[J]. Am J Med 1998; 104(3A); discussion 41S-42S.
|